By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxin, Inc. 

500 Beacon Parkway West

Birmingham  Alabama  35209  U.S.A.
Phone: 205-943-8621 Fax: 205-943-8565


Company News
Vaxin, Inc. Changes Company Name To Altimmune 9/2/2015 9:06:12 AM
Vaxin, Inc. First-in-Man Phase I Clinical Trial Initiated In Chronically Infected Hepatitis B Patients 7/27/2015 11:36:22 AM
Vaxin, Inc. Names Elizabeth Adkins Czerepak As Chief Financial Officer 4/13/2015 11:10:06 AM
Vaxin, Inc. CEO To Present At Future Leaders In The Biotech Industry Conference 3/18/2015 1:11:02 PM
Vaxin, Inc. Enters Definitive Agreement To Acquire Immune Targeting Systems (ITS) Ltd.; Secures $16M In New Financing 2/17/2015 8:04:37 AM
Vaxin, Inc. Awarded Biomedical Advanced Research and Development Authority (BARDA) Contract Valued at up to $21.7 Million to Develop Next Generation Anthrax Vaccine 9/19/2011 6:46:51 AM
Vaxin, Inc. Receives Birmingham Business Journal’s "Pacesetter" Award 4/30/2010 1:16:02 PM
Biotech Firm Vaxin, Inc. Taps New CEO, Looks for VC Funds 8/8/2008 7:00:28 AM
Birmingham Biotech Vaxin, Inc. Heading to Asia 5/4/2007 12:28:40 PM
Auburn University Researcher Develops Avian Flu Vaccine For Poultry 1/3/2007 11:39:50 AM